Synapsoft logo
AI Insights from Disclosures
Searching...
GENEMATRIX INC. 109820
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
GENEMATRIX INC. was established in December 2000 for the purpose of developing new drugs based on pharmaceutical development, including anticancer, antiviral, and antibiotic drugs through biotechnology, diagnostic agent development through gene mutation research, and the core technology derived from these. The company also develops and sells molecular diagnostic agents and medical diagnostic reagents, including biochemical reagents, that diagnose disease using self-developed proprietary technologies such as C-Tag, Encleap, TriO, and RFMP, and is developing vaccines and immuno-oncology treatments for disease prevention and treatment.
Representative Director Kim Suok
Founded December 7, 2000
Corporation Type KOSDAQ
Industry Classification Research and experimental development on medical sciences and pharmacy
Corporate number 11011-2124389
Business number 101-81-65547
Phone Number 031-628-2000
Fax Number 031-628-*2002
Company Address 700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant